MarketFriction

Take Ltd

NSE TAKE · BSE 532890 · Healthcare Research, Analytics & Technology
₹12.65 -4.96%
NSE close2026-10-01
52 week range11.05 - 50.14
Market cap₹208 Cr.
P/E35.2
ASM long-term Price band 5% Delivery 100.0%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales0.050.000.000.000.000.000.000.000.000.0054.1930.37
Expenses1.501.9815.762.220.902.891.150.440.300.3555.0130.64
Operating Profit-1.45-1.98-15.76-2.22-0.90-2.89-1.15-0.44-0.30-0.35-0.82-0.27
OPM %-2,900.00%-1.51%-0.89%
Other Income0.414.07-93.70-0.97-0.2351.31-3.48-0.296.921.465.181.33
Interest0.560.540.540.490.500.730.240.180.170.000.000.00
Depreciation0.300.110.010.010.010.010.010.000.000.000.000.00
Profit before tax-1.901.44-110.01-3.69-1.6447.68-4.88-0.916.451.114.361.06
Tax %-18.42%248.61%0.55%1.63%-3.66%0.00%0.00%0.00%2.48%0.00%0.00%0.00%
Net Profit-1.55-2.14-110.61-3.75-1.5847.68-4.88-0.916.291.114.361.06
EPS in Rs-0.10-0.14-7.48-0.25-0.113.22-0.33-0.060.430.080.290.07
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,0301,3451,5872,0392,213774655189405485
Expenses8171,0821,2811,6552,0448476482082475686
Operating Profit213262307384169-737-19-20-7-2-2
OPM %21%20%19%19%8%-9%1.1%-10%-569%-3.5%-2.1%
Other Income211361126-211-677-56-92471315
Interest1523212541372972200
Depreciation748710415416711580171000
Profit before tax145165188216-13-437-779-99-116371113
Tax %14%11%15%17%-15%3%0%2%3%0%1%
Net Profit125146160178-11-450-782-100-120371113
EPS in Rs9.7810.7410.8511.99-0.84-30.56-52.88-6.78-8.092.530.730.87
Dividend Payout %10%9%15%8%0%0%0%0%0%0%0%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth-26%-41%-34%%
Compounded Profit Growth-27%15%27%80%
Stock Price CAGR-22%-23%-14%28%
Return on Equity-10%-104%-47%17%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital121213151515151515151515
Reserves5126198981,3141,5041,5611,11016694-24616
Borrowings20933623732347455351459463700
Other Liabilities1892462211893393361879846960165
Total Liabilities9221,2141,3691,8402,3312,4651,8261,223224883636
Fixed Assets3595435545891,0911,234934101733000
CWIP17321424110311000
Investments62110591018700000
Other Assets5416477851,1501,1881,2138851,119140583636
Total Assets9221,2141,3691,8402,3312,4651,8261,223224883636
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity741515612110421113530209-16-4
Cash from Investing Activity-14-292-130-179-474-233-5715-3-7222
Cash from Financing Activity-111115630210021-84-55-36-12-3-1
Net Cash Flow49-30-18243-270-2-6-10-18-103-3
Free Cash Flow4635-3039-2354133-2-122-16-4
CFO/OP52%76%26%44%30%156%-212%704%-114%-43%217%208%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days1201071181089411620545587151
Inventory Days0
Days Payable
Cash Conversion Cycle1201071181089411620545587151
Working Capital Days42199085678014028-42-5,559123
ROCE %13%16%17%15%13%1%-9%-6%-14%-22%11%19%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters53.41%53.41%53.41%53.41%53.41%53.41%53.41%53.34%5.19%0.00%0.00%0.00%
FIIs0.00%0.00%0.02%0.00%0.00%0.00%0.00%0.00%0.00%0.56%0.28%0.20%
DIIs0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.00%0.00%0.00%0.00%0.00%
Public46.57%46.59%46.56%46.58%46.58%46.59%46.58%46.65%94.81%99.44%99.73%99.80%
No. of Shareholders81,18379,33681,93880,28878,03377,16375,98875,14174,41070,32464,69963,213

Fundamentals

Market Cap₹ 208 Cr.
Current Price₹ 14.0
Stock P/E35.2
Book Value₹ 2.10
ROCE18.5 %
ROE16.5 %
Dividend Yield0.00 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)%
Compounded Profit Growth (TTM)80%
Consolidated figures.
Valuation
Market capRs 187 Cr
Enterprise valueRs 187 Cr
P/E (TTM)14.60x
Price to book6.04x
Price to sales3.45x
EV / EBITDA14.01x
EV / EBIT14.02x
EV / sales3.45x
Earnings yield6.85%
P/E, 3-year average28.33x
P/B, 3-year average-3.48x
P/E, 5-year average28.33x
P/B, 5-year average-1.26x
Profitability
Operating margin (excl. other income)-3.52%
Operating margin (incl. other income)20.98%
EBITDA margin24.62%
Pre-tax margin23.95%
Net profit margin23.66%
Net margin, latest quarter3.49%
ROE42.12%
ROCE44.10%
ROA29.84%
ROE, 3-year average148.67%
ROCE, 3-year average27.39%
ROA, 3-year average4.48%
ROE, 5-year average51.39%
ROCE, 5-year average-8.77%
ROA, 5-year average-10.35%
ROIC (approx.)42.76%
Tax rate1.45%
Other income / net worth42.84%
Growth
Profit growth (latest year)-71.04%
Sales CAGR, 3 years-34.07%
Sales CAGR, 5 years-41.25%
Sales growth QoQ-43.96%
Profit growth QoQ-75.69%
Per share
EPS (TTM)Rs 0.87
EPS (latest year)Rs 0.73
EPS (latest quarter)Rs 0.07
EPS, 3-year averageRs -1.64
EPS, 5-year averageRs -13.05
Book value per shareRs 2.10
Sales per shareRs 3.66
Cash flow per shareRs -0.28
Free cash flow per shareRs -0.27
Efficiency
Asset turnover1.50x
Debtor days1 days
Debtors turnover246.32x
Cash conversion cycle1 days
Working capital days123 days
Leverage
Cash and bankRs 0 Cr
Net debtRs -0 Cr
Net debt / EBITDA-0.02x
Interest coverage38.09x
Owners' fund to total sources85.54%
Cash flow
Cash from Operating Activity (latest year)Rs -4 Cr
Cash from Investing Activity (latest year)Rs 2 Cr
Cash from Financing Activity (latest year)Rs -1 Cr
Net Cash Flow (latest year)Rs -3 Cr
Free cash flow (latest year)Rs -4 Cr
Statement figures
Net sales (TTM)Rs 54 Cr
Net sales (latest year)Rs 54 Cr
Sales (latest quarter)Rs 30 Cr
Operating profit excl. other income (latest year)Rs -2 Cr
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs 15 Cr
EBITDA (TTM)Rs 13 Cr
PBDT (TTM)Rs 13 Cr
Profit before tax (TTM)Rs 13 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs 13 Cr
Net profit (latest year)Rs 11 Cr
Net profit (latest quarter)Rs 1 Cr
Depreciation (TTM)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 54 Cr
Total expenditure (latest year)Rs 56 Cr
Total income (latest year)Rs 67 Cr
Share capitalRs 15 Cr
ReservesRs 16 Cr
Shareholders' fundsRs 31 Cr
Total assetsRs 36 Cr
ReceivablesRs 0 Cr
Other liabilitiesRs 5 Cr
Shares outstanding (crore)14.79
Ownership
Promoter holding0.00% (-53.34 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 14.6 is at the 56th percentile of its own 4.5-year range (median 13.8, low 3.3, high 392.2).
P/B 6.04 is at the 83th percentile (median 1.81).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodTAKENifty 50Difference
1 week-17.9%-2.8% -15.1 pts
1 month-13.2%-6.8% -6.4 pts
3 months-47.2%-7.6% -39.6 pts
6 months-68.1%+0.4% -68.5 pts
1 year+18.9%-9.9% +28.8 pts
2 years-33.5%-13.6% -19.9 pts
3 years-42.4%+14.2% -56.5 pts
5 years-75.5%+27.9% -103.4 pts

Red flags

F-score 3 of 6
explainHigh accruals Profit exceeded operating cash by 41% of total assets in 2026
lookProfit leans on other income Other income was 121% of pre-tax profit in 2026
lookAuditor change Auditor change 2026-03-26: Take Solutions Limited has informed the Exchange regarding Change in Auditors of the company.
lookOn NSE surveillance On NSE surveillance: ASM long-term
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹30 Cr. Net profit ₹1 Cr +216.5%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Syngene International Ltd14,82350.09.99 %
Indegene Ltd14,58035.018.8 %
Suven Life Sciences Ltd9,176-79.5 %
Vimta Labs Ltd2,64232.725.2 %
Fabtech Technologies Ltd66113.613.6 %
Bilcare Ltd22911.57.06 %
Novelix Pharmaceuticals Ltd19955.110.9 %
Jeevan Scientific Technology Ltd16346.75.01 %
Adeshwar Meditex Ltd2419.45.21 %
Vanta Bioscience Ltd151331.19 %
No bulk or block deals on record.
Ex-dateActionFactor
2024-08-07Annual General Meeting
2023-08-07Annual General Meeting
2022-12-15Annual General Meeting
2021-08-02 Annual General Meeting
2020-09-17 Annual General Meeting
2019-08-01 Dividend - Re 0.40 Per Share
2019-02-22 Interim Dividend - Re 0.30 Per Share
2018-11-09 Interim Dividend - Re 0.30 Per Share
2018-08-02 Annual General Meeting/Final Dividend- Re 0.40 Per Share/ Special Dividend- Re 0.60 Per Share (Purpose Revised)
2018-02-15 Interim Dividend Re 0.30 Per Share (Purpose Revised)
2017-11-17 Interim Dividend - Re 0.30 Per Share
2017-08-03 Dividend - Re 0.40/- Per Share
2017-02-16 Interim Dividend Re 0.30 Per Share
2016-11-17 Interim Dividend - Re 0.30 Per Share
2016-08-18 Annual General Meeting/ Dividend - Re 0.40/- Per Share
2016-02-17 Interim Dividend- Re 0.30/- Per Share
2015-11-23 Interim Dividend - Re 0.30/- Per Share
2015-08-20 Annual General Meeting/ Dividend - Re 0.40/- Per Share
2015-02-18Interim Dividend - Re 0.30/- Per Share
2014-11-25Interim Dividend - Re 0.30/- Per Share
2014-09-11Annual General Meeting / Dividend - Re 0.40/- Per Share
2014-02-11Interim Dividend - Re 0.30/- Per Share
2013-11-21Interim Dividend - Re 0.30/- Per Share
2013-08-29Annual General Meeting / Final Dividend - Re 0.40/- Per Share
2013-02-25Interim Dividend Re 0.30 Per Share
2012-11-23Interim Dividend-Re.0.30 Per Share
2012-08-30Annual General Meeting/ Dividend Rs 1 Per Share
2011-08-17Dividend-Re.1/- Per Share
2010-08-25Dividend-Re.0.20 Per Share (Bc End Date Revised)
2009-08-18Agm/Div-Re.0.20 Per Share
2008-09-18Fv Split-Rs10/- To Re.1/-0.1000
2008-07-30Agm/Dividend - 20%
DateTypeWhat it says
2026-10-01Shareholder meetingVoting results.
2026-09-29Shareholder meetingProceedings of Annual General Meeting held on September 29, 2026
2026-09-12Record DateIntimation of Cut-off Date for E-voting for the 25th Annual General Meeting.
2026-09-07Shareholder meetingNotice of Annual General Meeting to be held on September 29, 2026
2026-09-03Board meeting outcomeOutcome of Board Meeting held on September 03, 2026, regarding declaration of 25th Annual General Meeting and Other Matters.
2026-09-01Board meeting outcomeThe Board of Directors of the Company at its meeting held today, i.e. Tuesday, September 1, 2026, have inter alia considered and approved the Appointm...
2026-08-17Shareholder meetingVoting results.
2026-08-11Press ReleaseA press release dated August 11, 2026, titled "TAKE Limited delivers strong Q1 FY27 Performance with Consolidated Revenue of ₹30.37 Cr and Net P...
2026-08-11Board meeting outcomeTake Solutions Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-08-06Name ChangeMembers of the Exchange are hereby informed that the name of Take Solutions Limited will be changed to TAKE Limited w.e.f. August 12, 2026.
2026-07-13Shareholder meetingNotice of Postal Ballot
2026-07-09Board meeting outcomeOutcome of Board Meeting held on July 09, 2026.
2026-07-03Reply to Clarification- FinaThe Exchange had sought clarification from Take Solutions Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing...
2026-06-26Name ChangeReceipt of Certificate of Incorporation consequent upon change of name of the Company from TAKE SOLUTIONS LIMITED to TAKE LIMITED.
2026-06-22General UpdatesSubmission of Revised Audited Financial Results for the Quarter and Financial Year Ended March 31, 2026
2026-06-18Shareholder meetingTake Solutions Limited has submitted the Exchange Voting Results of Postal Ballot along with Scrutinizers Report.
2026-06-17Clarification - Financial ReThe Exchange has sought clarification from Take Solutions Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing...
2026-05-30Board meeting outcomeResignation and Appointment of Secretarial Auditor of the Company.
2026-05-20Press ReleasePress Release - TAKE Solutions Delivers Strong Financial Performance for FY26 with₹6,087 Lakhs Consolidated Total Income, registering a robust 4...
2026-05-20Board meeting outcomeTake Solutions Limited has submitted to the Exchange, the Standalone and Consolidated financial results for the year ended March 31, 2026.
2026-05-19Board meeting outcomeAppointment of Managing Director and Chief Financial Officer of the Company.
2026-05-15Shareholder meetingNotice of Postal Ballot
2026-05-13Board meeting outcomeOutcome of Board Meeting held on May 13, 2026.
2026-04-17Press ReleaseA press release dated April 17, 2026, titled "Take Solutions Announces plans to disrupt the Indian Longevity and Anti-ageing Solutions".
2026-04-06Press ReleaseA press release dated April 06, 2026, titled "TAKE Solutions Launches Rs. 50 Million Innovation Fund to Back AI, Deep Tech and Digital Health Startups...
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Long Term Additional Surveillance Measure (Long Term ASM): stage 1
Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.Updated 2026-10-03